Skip to main content
Clinical Trials/NCT00224666
NCT00224666
Terminated
Phase 2

Evaluation of the Effectiveness of Stimulation Cortex Sensorimotor for the Treatment of Rebel Neuropathic Pains

Assistance Publique - Hôpitaux de Paris1 site in 1 country16 target enrollmentMarch 2001

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Rebel Neuropathic Pains
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
16
Locations
1
Primary Endpoint
Efficacy of 50% of EVS at 3 weeks
Status
Terminated
Last Updated
19 years ago

Overview

Brief Summary

The pains chronic neurogeneses remain difficult to treat whatever are their origin and their localization. The pharmacological therapeutic arsenal answers only partially the symptomatology often very invalidating which these chronic painful patients present. Electric stimulations of the central nervous system currently validated, in particular of the posterior cords of marrow made a significant improvement in a certain number of indications. Nevertheless, considerable patients are not relieved significantly, in particular those presenting of the pains neurogeneses of central origin (syndromes thalamic for example). It is within this framework that recently the stimulation of the sensorimotor cortex developed.

Principal objective: evaluation of the technique of stimulation under cortical on neuropathic pains .

Detailed Description

The pains chronic neurogeneses remain difficult to treat whatever are their origin and their localization. The pharmacological therapeutic arsenal answers only partially the symptomatology often very invalidating which these chronic painful patients present. Electric stimulations of the central nervous system currently validated, in particular of the posterior cords of marrow made a significant improvement in a certain number of indications. Nevertheless, considerable patients are not relieved significantly, in particular those presenting of the pains neurogeneses of central origin (syndromes thalamic for example). It is within this framework that recently the stimulation of the sensorimotor cortex developed.

Registry
clinicaltrials.gov
Start Date
March 2001
End Date
November 2005
Last Updated
19 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Neurofibromatosis,
  • Rebel chronic neuropathic pain with duration \> 1 year and AVS \> = 4

Exclusion Criteria

  • Cognitive deterioration

Outcomes

Primary Outcomes

Efficacy of 50% of EVS at 3 weeks

Secondary Outcomes

  • Efficacy of 50% of EVS at 6 months and 12 months

Study Sites (1)

Loading locations...

Similar Trials